Maria Beconi,Daniel Elbaum,Steven Harper,Savina Malancona
申请号：
US16060347
公开号：
US10364263B2
申请日:
2016.12.08
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Compounds having the following formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, D, E and R1 are as defined herein, are provided. Methods comprising the use of such compounds for the treatment of neurological disorders, such as pantothenate kinase-associated neurodegeneration, and pharmaceutical compositions containing such compounds, and their use in the treatment of neurological disorders, also are provided.
